Marino Marco Vito, Shabat Galyna, Potapov Oleksii, Gulotta Gaspare, Komorowski Andrzej L
a Department of Emergency and General Surgery , P. Giaccone Hospital, University of Palermo , Palermo , Italy.
b Department of Surgical Oncology , Maria Skłodowska-Curie Memorial Institute of Oncology Cancer Centre , Kraków , Poland.
Acta Chir Belg. 2019 Feb;119(1):16-23. doi: 10.1080/00015458.2018.1444550. Epub 2018 Mar 8.
Described for the first time in 2003, the robotic pancreatic surgery shows interesting results. The evaluation of post-operative outcomes is necessary once we describe an innovative surgical approach.
We have performed a retrospective analysis of a prospectively maintained database on robotic pancreatic surgery including malignant and benign indications for surgery.
A total of 50 consecutive patients underwent robotic pancreatic surgery (26 pancreatico duodenectomy and 24 distal pancreatectomy) between January 2012 and July 2015 in a single centre. The overall operative time was 425 (390-620) min. In a subgroup of highly selected malignant tumours, we were able to achieve 88% of R0 resection with robotic approach. A number of lymphnodes rose significantly with growing experience (p = .025). The overall major complication rate (15%), as well as pancreatic fistula rate (16%) were acceptable. The two-year overall survival for the whole group was 65%.
The robotic pancreatic surgery in a highly selected group of patients seems safe and feasible. The cost-effectiveness and long-term oncologic outcomes need further investigations.
机器人胰腺手术于2003年首次被描述，显示出令人感兴趣的结果。一旦我们描述了一种创新的手术方法，对术后结果进行评估是必要的。
我们对一个前瞻性维护的机器人胰腺手术数据库进行了回顾性分析，该数据库包括手术的恶性和良性指征。
在2012年1月至2015年7月期间，一个中心共有50例连续患者接受了机器人胰腺手术（26例胰十二指肠切除术和24例胰腺远端切除术）。总体手术时间为425（390 - 620）分钟。在一组高度选择的恶性肿瘤亚组中，我们通过机器人手术方法实现了88%的R0切除。随着经验的增加，淋巴结数量显著增加（p = 0.025）。总体主要并发症发生率（15%）以及胰瘘发生率（16%）是可以接受的。整个组的两年总生存率为65%。
在一组高度选择的患者中，机器人胰腺手术似乎是安全可行的。成本效益和长期肿瘤学结果需要进一步研究。
